Chronopharmacological dependence of antihypertensive effects of the imidazoline-like drugs in stroke-prone spontaneously hypertensive rats

Journal of the Autonomic Nervous System

Volumn 72, Issue 2-3, 1998, Pages 170-176

  Medvedev, Oleg S ^a   Kunduzova, Oksana R ^a   Murashev, Arkady N ^b   Medvedeva, Natalya A ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

Chronopharmacology; Clonidine; Hypertension; Imidazoline; Moxonidine; Rilmenidine

Indexed keywords

CLONIDINE; IMIDAZOLINE DERIVATIVE; MOXONIDINE; RILMENIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CHRONOPHARMACOLOGY; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; HYPERTENSION; LOCOMOTION; MALE; NIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TELEMETRY; TIME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBROVASCULAR DISORDERS; CIRCADIAN RHYTHM; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HYPERTENSION; IMIDAZOLES; MALE; MOTOR ACTIVITY; OXAZOLES; RATS; RATS, INBRED SHR;

EID: 0031755121     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(98)00102-7     Document Type: Article

References (21)

1. Bricca, G., Dontenwill, M., Molines, A., Feldman, J., Tibirica, E., Belcourt, A. et al., 1989. Rilmenidine selectivity for imidazoline receptors in human brain. Eur. J. Pharmacol. 163, 373-377.
2. Ernsberger, P., Giuliano, R., Willette, R.N., Granata, A.R., Reis, D.J., 1988. Hypotensive action of clonidine analogs correlates with binding affinity at imidazole and not alpha-2 adrenergic receptors in the rostral ventrolateral medulla. J. Hypertens. 6, S554-S557, (Suppl. 6).
3. Ernsberger, P., Westbrooks, K.L., Christen, N.O., Schafer, S.G., 1992. A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors. J. Cardivasc. Pharmacol. 20, S1-S10, (Suppl. 4).
4. Ernsberger, P., Damon, T.H., Graff, L.M., Christen, M.O., Schafer, S.G., 1993. Moxonidine, a centrally-acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. J. Pharmacol. Exp. Ther. 264, 172-182.
5. Ernsberger, P., Haxhiu, M.A., Graff, L.M., Collins, L.A., Dreshaj, I., Grove, D.L., Graves, M.E., Schafer, S.G., Christen, M.O., 1994. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist. Cardiovasc. Drugs. Ther. 8, 27-41, (Suppl. 1).
6. Janssen, B.J.A., Tyssen, C.M., Struyker Boudier, H.A.J., 1991. Modification of circadian blood pressure and heart rate variability by five different antihypertensive agents in spontaneously hypertensive rats. J. Cardivasc. Pharmacol. 17, 494-503.
7. Janssen, B.J., Oosting, J., Tyssen, C.M., Struyker Boudier, H.A., 1993. Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats. Chronobiol. Int. 10 (6), 420-434.
8. Kawashima, K., Negishi, T., Amano, H., Fujimoto, K., Suzuki, T., Fujii, T., 1995. Antihypertensive effects, determined by a telemetry method, of trichloromethiazide and 7-O-ethylfangchinoline, a derivative of tetrandrine, in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 22, S300-S301, (Suppl. 1).
9. Kobinger, W., 1978. Central alpha-adrenergic systems as targets for hypotensive drugs. Rev. Physiol. Biochem. 81, 39-100.
10. Lemmer, B., Nold, G., Behne, S., Kaiser, R., 1991. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol. Int. 8 (60), 485-494.
11. Lemmer, B., Witte, K., Makabe, T., Ganten, D., Mattes, A., 1994. Effects of enalaprilat on circadian profiles in blood pressure and heart rate of spontaneously and transgenic hypertensive rats. J. Cardiovasc. Pharmacol. 23 (2), 311-314.
12. McKaigue, J.P., Harron, D.W., 1992. The effects of rilmenidine on tests of autonomic function in humans. Clin. Pharmacol. Ther. 52, 511-517.
13. Nakanishi, T., Takahashi, H., Nishimura, M., Yoshimura, M., 1993. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure. Clin. Ther. 15 (2), 294-303.
14. Teerlink, J.R., Clozel, J.P., 1993. Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity. Am. J. Physiol. 264, H2111-H2118, (6 Pt 2).
15. Timmermans, P.B.M.W.M., Van Zwieten, P.A., 1982. Alpha-adrenoreceptors classification, localization, mechanisms, and targets for drugs. J. Med. Chem. 25, 1389-1401.
16. Timmermans, P.B.M.W.M., Schoop, A.M.C., Kwa, H.Y., Van Zwieten, P.A., 1981. Characterization of alpha-adrenergic receptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine, and corynanthine. Eur. J. Pharmacol. 70, 7-15.
17. Udvary, E., Schafer, S.G., Vegh, A., Szekeers, L., 1990. Haemodynamic effects of a new centrally acting agent moxonidine as compared to clonidine. Eur. J. Pharmacol. 183, 2064.
18. Van Den Buuse, M., 1994. Circadian rhythms of blood pressure, heart rate, and locomotor activity in spontaneously hypertensive rats as measured with radio-telemetry. Physiology and Behavior 55 (4), 783-787.
19. Van Zwieten, P.A., 1995. Central imidazoline receptors as a target for centrally acting antihypertensive drugs. Pharm. World. Sci. 17 (6), 186-190.
20. Van Zwieten, P.A., 1997a. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine. J. Hypertens. 15, 117-125.
21. Van Zwieten, P.A., 1997b. Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics. J. Hypertens. 15 (1), S3-S8, Suppl.